<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:department>Clinical Science at North Bristol</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4A606E1D-6DFA-421F-850B-633910FA5299"><gtr:id>4A606E1D-6DFA-421F-850B-633910FA5299</gtr:id><gtr:firstName>Neil</gtr:firstName><gtr:surname>Sebire</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/438CF1E1-40A8-469C-995E-CBDE54B96F74"><gtr:id>438CF1E1-40A8-469C-995E-CBDE54B96F74</gtr:id><gtr:firstName>Caroline</gtr:firstName><gtr:otherNames>Olive</gtr:otherNames><gtr:surname>Savage</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/318CB97D-2B9D-4E22-A06E-71F48A7EECD0"><gtr:id>318CB97D-2B9D-4E22-A06E-71F48A7EECD0</gtr:id><gtr:firstName>Charles</gtr:firstName><gtr:otherNames>Richard</gtr:otherNames><gtr:surname>Tomson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/32B7831D-543F-4979-BB43-6B2AAF8208AC"><gtr:id>32B7831D-543F-4979-BB43-6B2AAF8208AC</gtr:id><gtr:firstName>C</gtr:firstName><gtr:otherNames>Mark</gtr:otherNames><gtr:surname>Taylor</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F69DF933-A746-4209-BDCB-50A3B12F63C2"><gtr:id>F69DF933-A746-4209-BDCB-50A3B12F63C2</gtr:id><gtr:firstName>Moin</gtr:firstName><gtr:surname>Saleem</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0800571"><gtr:id>EB92724D-53F1-4AE0-953A-FB37B1D9BEED</gtr:id><gtr:title>National studies of kidney disease in childhood and adolescence</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0800571</gtr:grantReference><gtr:abstractText>Kidney disease in children is rare, but highly demanding, both for the families and children, and for the medical services. The majority of the workload is managed in specialist children s hospitals, and requires facilities for dialysis and transplantation. If the diseases that lead to kidney failure could be studied more systematically, by collecting clinical information, blood and DNA samples from the whole UK population, then better strategies for preventing kidney failure could be devised. 
This study will collect information from 2 such diseases, in an ongoing basis, and has the robust support of all the leading UK kidney organisations. This will be the first time such comprehensive disease information has been collated, and will set up an infrastructure for many more kidney diseases to be studied in the same comprehensive way.</gtr:abstractText><gtr:technicalSummary>The proposal is to develop a national cohort of two kidney diseases that present in childhood and adolescence, mesangiocapillary glomerulonephritis (MCGN) and focal segmental glomerulosclerosis (FSGS). These diseases are rare, progress to end-stage renal failure and are resistant to conventional immunosuppressive therapies. Health service costs attributable to these disorders in young subjects are disproportionately high. Both disorders lend themselves to modern investigation with new insights into abnormal complement regulation in MCGN and gene mutations that affect the glomerular epithelial cell (podocyte) in FSGS. 

The proposal has the emphatic support of the relevant national organizations. To overcome the problem of disease rarity investigators will collaborate across all tertiary regional paediatric nephrology centers. A generic web-based data entry and management system will be developed: analysis will be centralized. The phenotype will be extensively defined by standardized investigations with expert peer review of the renal pathology to include stratification for chronic renal damage. There will be special investigations specific to each cohort. For MCGN this will include centralized investigation of complement activity and the role of antibodies that are thought to either induce complement dysregulation or participate in immune complex formation in the kidney. For FSGS it will include screening for known causative gene mutations. For both cohorts a biorepository will be established.

The cohorts will be large enough to permit prospective clinical trials, and for both disorders there are novel proposals for treatment. A steering committee to promote and regulate access will supervise each cohort. Consideration has been given to the long-term follow up of participants, particularly the transfer into adult medical supervision. The development of these cohorts is a test case for the renal community to develop similar studies of other rare kidney disease in association with the UK Renal Registry.</gtr:technicalSummary><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>349929</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>National Renal Rare Disease Consortium</gtr:description><gtr:id>71477D56-5B73-409A-8B5F-529BFACD7BBD</gtr:id><gtr:impact>A National policy document has been drawn up to inform government, funding bodies and nephrologists about this multilevel initiative</gtr:impact><gtr:piContribution>the RADAR website will be a central data repository for this initiative</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Patient entry of data onto website</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>69AE8B20-1561-4CEC-BF18-AF8AEF7F6F63</gtr:id><gtr:impact>The MRC registry includes, as a core part of its work, the ability of patients/carers to both see their own data entered, and to enter specific data themselves, and also to see patient information, forums etc., all on the website created for the Registry.

Patient empowerment</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://www.renalradar.org</gtr:url><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Renal Society Patient Support Gropu</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4765208E-D02D-49FD-B30F-B7F8CDC72098</gtr:id><gtr:impact>Presentation of registry work at a national conference for multiprofessional team members and patient groups

Wider patient awareness.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Video made for Nephrotic Syndrome Trust charity - put up on YouTube</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7D134C6A-3BE1-4F78-8B80-15E2FD13E1A9</gtr:id><gtr:impact>Professionally produced video highlighting Nephrotic Syndrome and the research activities in Bristol, commissioned by the Nephrotic Syndrome Trust</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.youtube.com/watch?v=4VpPSqG_ioM</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>National Patient engagement day 2015</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>42849D04-5849-4ADF-9783-4DB63216ABAB</gtr:id><gtr:impact>40-50 patients and families attended a national engagement day for nephrotic syndrome, hosted in Birmingham</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>National Nephrotic Syndrome Patients' Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FF0FD8E5-4943-4398-B96F-B6A15606C086</gtr:id><gtr:impact>National patient day - presentations, Q+A, and tours of research labs</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>228362</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>National Institute for Health Research (NIHR)</gtr:department><gtr:description>NIHR rare disease fellowship</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>University College London Hospitals Charity (UCLH)</gtr:fundingOrg><gtr:id>54633E3D-A884-41C6-B8BC-0CEF2EA148E9</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>35000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>KRUK Project Grant</gtr:description><gtr:end>2012-01-02</gtr:end><gtr:fundingOrg>Kidney Research UK</gtr:fundingOrg><gtr:id>9406854D-9456-4DB8-925A-D30DF63A6B33</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>586833</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>MRC Research Grant</gtr:department><gtr:description>Global Challenges Research Fund</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>712632E4-B1A6-4A9C-81E3-CEC97C4773A5</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UKIERI</gtr:description><gtr:end>2015-02-02</gtr:end><gtr:fundingOrg>British Council</gtr:fundingOrg><gtr:id>722AF32E-684D-437D-BD9F-ACB9E7CBA220</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>225000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>SRNS registry development</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>NephCure?Foundation</gtr:fundingOrg><gtr:id>65ED2A37-61A0-4439-AE3E-348F26E24652</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>174000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>National Institute for Health Research (NIHR)</gtr:department><gtr:description>NIHR TRC</gtr:description><gtr:end>2016-01-02</gtr:end><gtr:fundingOrg>University College London Hospitals Charity (UCLH)</gtr:fundingOrg><gtr:id>796314A2-7E47-465A-80AB-F27220A005B8</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>199702</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR-TRC Industry</gtr:description><gtr:end>2017-07-02</gtr:end><gtr:fundingOrg>National Institute for Health Research (NIHR)</gtr:fundingOrg><gtr:id>1238C173-2805-4C16-958A-5EDBA969525D</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2015-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>137520</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Industry partnership studentship</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>C3263F71-DDBF-4975-8874-36B3FC1604E6</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Kids Kidney Research project grant</gtr:description><gtr:end>2012-07-02</gtr:end><gtr:fundingOrg>Kids Kidney Research</gtr:fundingOrg><gtr:id>987849E6-9064-42BE-853A-FD37BB9A6BD0</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Special funding for development of RaDaR database</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>Kidney Research UK</gtr:fundingOrg><gtr:id>D60A75A5-ED3B-4F2C-8D16-1E97DC46A393</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Kidney Research UK project grant</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>Kids Kidney Research</gtr:fundingOrg><gtr:id>50FEAD22-5C91-4827-9151-7BF11C6341DF</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Investment by UCB Pharma to help develop the cohort and collect biomarkers</gtr:description><gtr:id>C0ABF748-22EE-433E-865C-39D51F61FE28</gtr:id><gtr:impact>Ongoing</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:protection>Protection not required</gtr:protection><gtr:title>Industry investment</gtr:title><gtr:yearProtectionGranted>2014</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>National Rare Kidney Disease Policy</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1876EF3F-DA0A-43FD-B3CD-CB140D63265B</gtr:id><gtr:impact>The registry will be a central part of the new initiative for management of rare renal disease in the UK</gtr:impact><gtr:type>Participation in advisory committee</gtr:type><gtr:url>https://www.orpha.net/data/prj/GB/ID73928EN.pdf</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>creation of national renal rare disease committee</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>36BBB302-00CF-4F99-8720-21AAF59D1E63</gtr:id><gtr:impact>New committee to oversee national policy - under governance of UK Renal Association</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Application to UK Genetic Testing Network for Next Generation Sequencing diagnostic test for SRNS - fully approved, and nationally commissioned</gtr:description><gtr:id>24F73D92-A555-4343-9928-A9189C318B73</gtr:id><gtr:impact>One step genetic screening for 24 genes associated with SRNS - this is a major advance in diagnosing and appropriate clinical management of patients with monogenenic disease.</gtr:impact><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Clinical Genetic testing for Steroid Resistant Nephrotic Syndrome</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:url>http://rarerenal.org/wp-content/uploads/2013/05/SRNS-genetic-testing.pdf</gtr:url><gtr:yearDevCompleted>2012</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>National UK Renal Rare Disease Registry</gtr:description><gtr:id>A48B2F1F-CB64-431B-ACCA-98706D2CAEFB</gtr:id><gtr:impact>Nationally recruiting patients with rare diseases to a web based registry. A governance structure has been set up with a Rare Disease Committee, reporting to the UK Renal Association, and IT based in the UK Renal Registry. Currently 18 different renal rare disease groups have been formed in the UK, utilising this database for data entry and analysis</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Renal Radar</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://www.renalradar.org</gtr:url><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>International version of the UK Rare Disease Registry, initially for use by the collaborating centres on my MRC Global Challenges award, ultimately for use by all Rare Disease Groups (IgA nephropathy group will be the second 'early adopter' of this Registry).</gtr:description><gtr:id>6C4C1A8D-616C-4E91-A629-C453279C4A4D</gtr:id><gtr:impact>Newly created - will be a long-term infrastructure for use by many disease groupings</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>International RaDaR</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://www.internationalradar.org</gtr:url><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Clinical, phenotypic and biomarker collection from all UK patients with this condition</gtr:description><gtr:id>B25D8A15-7BB3-4533-A077-BB08ABDF6C2E</gtr:id><gtr:impact>Genotypic data being fed back to clinicians, and being prepared for publication</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>SRNS national cohort of children</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>genetic analysis using a new technique - deep sequencing of 500 genes per patient</gtr:description><gtr:id>11AE75D8-198B-472D-B333-20DA1884F53F</gtr:id><gtr:impact>Developed into a clinical genetic test</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Next generation sequencing of DNA samples</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Phenotypic database of all UK children. Sample and biomarker collection to follow.</gtr:description><gtr:id>3A525B39-82DB-4D4D-89C0-771DD2B3C7D6</gtr:id><gtr:impact>None yet</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>National collection of MPGN patients</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>website for ongoing data collection on a national comprehensive basis; patient information; clinician information; trial data entry; patient management.</gtr:description><gtr:id>01FB6CC4-D258-4D12-8A5B-53BC0305850C</gtr:id><gtr:impact>Data collection will commence 2009/10</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>RADAR website</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://www.renalradar.org</gtr:url><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2944BD85-E464-4249-AE92-18C78B13AC05"><gtr:id>2944BD85-E464-4249-AE92-18C78B13AC05</gtr:id><gtr:title>ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/871fb67d900be1518e71811bda7c2c0d"><gtr:id>871fb67d900be1518e71811bda7c2c0d</gtr:id><gtr:otherNames>Ashraf S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4EEF7C18-8EEB-439B-B60B-3A9F173D0384"><gtr:id>4EEF7C18-8EEB-439B-B60B-3A9F173D0384</gtr:id><gtr:title>Cell biology and genetics of minimal change disease.</gtr:title><gtr:parentPublicationTitle>F1000Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/27b676a94efbdebd5ec821d522896233"><gtr:id>27b676a94efbdebd5ec821d522896233</gtr:id><gtr:otherNames>Saleem MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2046-1402</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0588663E-42E1-4CFA-BCBD-6B576EB05785"><gtr:id>0588663E-42E1-4CFA-BCBD-6B576EB05785</gtr:id><gtr:title>Recent advances in understanding and treating nephrotic syndrome.</gtr:title><gtr:parentPublicationTitle>F1000Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/82e4ce55ad0283b97d594815711ee232"><gtr:id>82e4ce55ad0283b97d594815711ee232</gtr:id><gtr:otherNames>Bierzynska A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2046-1402</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FDAF6C4F-0F29-4B7E-9F0D-59EAB20D28AC"><gtr:id>FDAF6C4F-0F29-4B7E-9F0D-59EAB20D28AC</gtr:id><gtr:title>Genetics in clinical practice: nephrotic and proteinuric syndromes.</gtr:title><gtr:parentPublicationTitle>Nephron. Experimental nephrology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/de43769b598048f3a820a968b5da551c"><gtr:id>de43769b598048f3a820a968b5da551c</gtr:id><gtr:otherNames>McCarthy HJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1660-2129</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DB368C52-DB53-4BE0-A531-28E441547765"><gtr:id>DB368C52-DB53-4BE0-A531-28E441547765</gtr:id><gtr:title>Coinheritance of COL4A5 and MYO1E mutations accentuate the severity of kidney disease.</gtr:title><gtr:parentPublicationTitle>Pediatric nephrology (Berlin, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/54ab7e3bb69e1fb68a55a57b0178c654"><gtr:id>54ab7e3bb69e1fb68a55a57b0178c654</gtr:id><gtr:otherNames>Lennon R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0931-041X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/259E217F-50AB-41E2-AC65-D1E2C2D3F2BB"><gtr:id>259E217F-50AB-41E2-AC65-D1E2C2D3F2BB</gtr:id><gtr:title>Active proteases in nephrotic plasma lead to a podocin-dependent phosphorylation of VASP in podocytes via protease activated receptor-1.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6a09ff1f8e2250c474f4ecb680cb7f88"><gtr:id>6a09ff1f8e2250c474f4ecb680cb7f88</gtr:id><gtr:otherNames>Harris JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CF224426-61E7-4398-807B-74F30547EE46"><gtr:id>CF224426-61E7-4398-807B-74F30547EE46</gtr:id><gtr:title>NPHS2 mutations in steroid-resistant nephrotic syndrome: a mutation update and the associated phenotypic spectrum.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c2cdb884ea26b675298db8003f6da36e"><gtr:id>c2cdb884ea26b675298db8003f6da36e</gtr:id><gtr:otherNames>Bouchireb K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/414F144A-BD66-4EDD-9D54-75EE92A05005"><gtr:id>414F144A-BD66-4EDD-9D54-75EE92A05005</gtr:id><gtr:title>One hundred ways to kill a podocyte.</gtr:title><gtr:parentPublicationTitle>Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/27b676a94efbdebd5ec821d522896233"><gtr:id>27b676a94efbdebd5ec821d522896233</gtr:id><gtr:otherNames>Saleem MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0931-0509</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D08718CC-BF55-4EF7-9284-41F3D8321FEF"><gtr:id>D08718CC-BF55-4EF7-9284-41F3D8321FEF</gtr:id><gtr:title>Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e5667e70b093be20e803ab5501a73bd6"><gtr:id>e5667e70b093be20e803ab5501a73bd6</gtr:id><gtr:otherNames>Beckerman P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/837E5DB8-9070-4E8E-A280-5EC9B4B672DB"><gtr:id>837E5DB8-9070-4E8E-A280-5EC9B4B672DB</gtr:id><gtr:title>Simultaneous sequencing of 24 genes associated with steroid-resistant nephrotic syndrome.</gtr:title><gtr:parentPublicationTitle>Clinical journal of the American Society of Nephrology : CJASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/de43769b598048f3a820a968b5da551c"><gtr:id>de43769b598048f3a820a968b5da551c</gtr:id><gtr:otherNames>McCarthy HJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1555-9041</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5318E05E-06D9-4708-B14C-17B08593CD15"><gtr:id>5318E05E-06D9-4708-B14C-17B08593CD15</gtr:id><gtr:title>MAGI2 Mutations Cause Congenital Nephrotic Syndrome.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/82e4ce55ad0283b97d594815711ee232"><gtr:id>82e4ce55ad0283b97d594815711ee232</gtr:id><gtr:otherNames>Bierzynska A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7E07D963-E3F7-472C-A02B-438C3789CFCB"><gtr:id>7E07D963-E3F7-472C-A02B-438C3789CFCB</gtr:id><gtr:title>FAT1 mutations cause a glomerulotubular nephropathy.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c60c7f318fcd3925ea7e919341038412"><gtr:id>c60c7f318fcd3925ea7e919341038412</gtr:id><gtr:otherNames>Gee HY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6EB19FFD-8BDA-4AD4-AB48-844AA3FE56A6"><gtr:id>6EB19FFD-8BDA-4AD4-AB48-844AA3FE56A6</gtr:id><gtr:title>Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management.</gtr:title><gtr:parentPublicationTitle>Kidney international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/82e4ce55ad0283b97d594815711ee232"><gtr:id>82e4ce55ad0283b97d594815711ee232</gtr:id><gtr:otherNames>Bierzynska A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0085-2538</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/36592CF0-786D-49DC-894A-FBFB213302EE"><gtr:id>36592CF0-786D-49DC-894A-FBFB213302EE</gtr:id><gtr:title>Defects of CRB2 cause steroid-resistant nephrotic syndrome.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/232708da4ffa4f4a2b25b8538b1c8384"><gtr:id>232708da4ffa4f4a2b25b8538b1c8384</gtr:id><gtr:otherNames>Ebarasi L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1041BE28-FA52-42DF-B3E0-D28EE178959B"><gtr:id>1041BE28-FA52-42DF-B3E0-D28EE178959B</gtr:id><gtr:title>VEGF regulates local inhibitory complement proteins in the eye and kidney.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a1c1ce1e3361cf7210c0858e347d1ea2"><gtr:id>a1c1ce1e3361cf7210c0858e347d1ea2</gtr:id><gtr:otherNames>Keir LS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800571</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>2EEE0958-6BE1-4D16-B86B-5D954CD37219</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Renal and Urogenital</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>5191BE6E-A234-4D62-A4F3-B50DBAAE8217</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>4.5  Resources and infrastructure (detection)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>208C592B-C1B7-4E87-A19A-04E8D9458E50</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>6.9  Resources and infrastructure (evaluation of treatments)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>